Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Other Operating Expenses (2019 - 2024)

Historic Other Operating Expenses for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2024 value amounting to -$3000.0.

  • Benitec Biopharma's Other Operating Expenses changed N/A to -$3000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was -$3000.0, marking a year-over-year increase of 9714.29%. This contributed to the annual value of -$108000.0 for FY2024, which is N/A changed from last year.
  • As of Q1 2024, Benitec Biopharma's Other Operating Expenses stood at -$3000.0.
  • In the past 5 years, Benitec Biopharma's Other Operating Expenses registered a high of $134000.0 during Q3 2020, and its lowest value of -$106000.0 during Q3 2023.
  • Over the past 5 years, Benitec Biopharma's median Other Operating Expenses value was $4000.0 (recorded in 2021), while the average stood at $11900.0.
  • As far as peak fluctuations go, Benitec Biopharma's Other Operating Expenses tumbled by 9791.67% in 2021, and later skyrocketed by 80000.0% in 2022.
  • Benitec Biopharma's Other Operating Expenses (Quarter) stood at -$19000.0 in 2020, then surged by 105.26% to $1000.0 in 2021, then soared by 800.0% to $9000.0 in 2022, then plummeted by 88.89% to $1000.0 in 2023, then plummeted by 400.0% to -$3000.0 in 2024.
  • Its last three reported values are -$3000.0 in Q1 2024, $1000.0 for Q4 2023, and -$106000.0 during Q3 2023.